Where does Adherium (NZ) Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adherium (NZ) Limited ranks #13,832 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adherium (NZ) Limited hold?

Adherium (NZ) Limited holds 21 US utility patents granted between 2019 and 2025, spanning 5 technology areas.

What is Adherium (NZ) Limited's Innovation Score?

Adherium (NZ) Limited has an Innovation Score of 29.4 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Adherium (NZ) Limited's patent grant rate increasing or decreasing?

Adherium (NZ) Limited's recent grant velocity is +225% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Adherium (NZ) Limited's patents?

Adherium (NZ) Limited's patents average 10.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adherium (NZ) Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Adherium (NZ) Limited

Q: What technology areas does Adherium (NZ) Limited focus on?

Adherium (NZ) Limited's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 10 patents, ranking #701 of 3,490 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adherium ranks #13,832 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 5 technology areas.

#13,832
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.4/100): 10.3
avg claims per patent: +225%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13832 · Foreign Corporation #13,832 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,832/49,997
PHOTO-FINISH Acerta Pharma B V
CPC-NARROW A61M · 5 areas
INNOV-THIN 29.4/100
CLAIMS-PAR 10.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +225% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acerta Pharma B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adherium’s 29.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (36%) Velocity 4.7 pts (16%) Breadth 7.9 pts (27%) Claim depth 6.2 pts (21%)

Qualcomm Incorporated · highest

85
Adherium (NZ) · this assignee

29
3D Lighting… · lowest

7

What this shows Adherium's Innovation Score is 29.4/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Adherium?

Each dot is one of Adherium’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adherium’s own 10.3 claims/patent is at or below the 15.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Adherium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adherium's grants concentrate

Adherium (NZ) Limited is a focused PatentsView assignee: 5 CPC subclasses with 47.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2021. By volume, Adherium sits between Avantec Vascular Corporation and Air Squared, Inc..

Adherium's three-year grant acceleration

Adherium (NZ) Limited shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Avantec Vascular

21
Acerta Pharma B V

21
Active Implants

21
Adasky

21
Aduro Biotech

21
Advanced Fusion S…

21
Adverio Pharma

21
Air Squared

21
Adherium (NZ) ◀

21

What this shows Adherium holds 21 patents at rank #13,854, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adherium

By rank, the assignees closest to #13,854 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Adherium's primary technology class.

Adherium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Adherium (NZ) Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	19.0%
2020	5	23.8%
2021	1	4.8%
2022	1	4.8%
2023	5	23.8%
2024	1	4.8%
2025partial year	4	19.0%

Which technologies does Adherium (NZ) Limited patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

A61B - DIAGNOSIS; SURGERY; Identification 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Adherium (NZ) Limited's patent record in context - here's where to go next.

Adherium (NZ) Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 47.6% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #13,832 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adherium (NZ) Limited against Avantec Vascular Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.